Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
Patel NJ, Wang X, Lin M, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Williams ZK, Hanberg JS, Kawano Y, Schiff AE, Sparks JA, Wallace ZS. Patel NJ, et al. Among authors: bade kj. J Rheumatol. 2024 May 1;51(5):529-537. doi: 10.3899/jrheum.2023-1092. J Rheumatol. 2024. PMID: 38428964 Free article.
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
Qian G, Wang X, Patel NJ, Kawano Y, Fu X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Bade KJ, Srivatsan S, Williams ZK, Todd DJ, Weinblatt ME, Wallace ZS, Sparks JA. Qian G, et al. Among authors: bade kj. medRxiv [Preprint]. 2022 Oct 30:2022.10.27.22281629. doi: 10.1101/2022.10.27.22281629. medRxiv. 2022. Update in: Lancet Rheumatol. 2023 Mar;5(3):e139-e150. doi: 10.1016/S2665-9913(23)00006-1 PMID: 36324801 Free PMC article. Updated. Preprint.
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study.
Schiff AE, Wang X, Patel NJ, Kawano Y, Kowalski EN, Cook CE, Vanni KMM, Qian G, Bade KJ, Saavedra AA, Srivatsan S, Williams ZK, Venkat RK, Wallace ZS, Sparks JA. Schiff AE, et al. Among authors: bade kj. medRxiv [Preprint]. 2023 Oct 9:2023.10.08.23296717. doi: 10.1101/2023.10.08.23296717. medRxiv. 2023. Update in: Ann Rheum Dis. 2024 Apr 11;83(5):680-682. doi: 10.1136/ard-2023-225162 PMID: 37873462 Free PMC article. Updated. Preprint.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Schiff AE, Wang X, Patel NJ, Kawano Y, Hanberg JL, Kowalski EN, Cook CE, Vanni KM, Qian G, Bade KJ, Saavedra AA, Srivatsan S, Williams ZK, Venkat RK, Wallace ZS, Sparks JA. Schiff AE, et al. Among authors: bade kj. Ann Rheum Dis. 2024 Apr 11;83(5):680-682. doi: 10.1136/ard-2023-225162. Ann Rheum Dis. 2024. PMID: 38199795 No abstract available.
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Hanberg JS, Fu X, Wang X, Patel NJ, Kawano Y, Schiff A, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Zhang Y, Sparks JA, Wallace ZS. Hanberg JS, et al. Among authors: bade kj. Lancet Rheumatol. 2024 Jan;6(1):e21-e30. doi: 10.1016/S2665-9913(23)00272-2. Epub 2023 Nov 15. Lancet Rheumatol. 2024. PMID: 38258675 Free PMC article. Clinical Trial.
Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.
Venkat RK, Hayashi K, Juge PA, McDermott G, Paudel M, Wang X, Vanni KMM, Kowalski EN, Qian G, Bade KJ, Saavedra AA, Mueller KT, Chang SH, Dellaripa PF, Weinblatt ME, Shadick NA, Doyle TJ, Dieude P, Sparks JA. Venkat RK, et al. Among authors: bade kj. Clin Rheumatol. 2024 Aug;43(8):2453-2466. doi: 10.1007/s10067-024-07028-w. Epub 2024 Jun 19. Clin Rheumatol. 2024. PMID: 38898318
Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes.
McDermott GC, Hayashi K, Juge PA, Gill R, Byrne S, Gagne S, Wang X, Paudel ML, Moll M, Cho MH, Vanni K, Kowalski E, Qian G, Bade K, Saavedra A, Kawano Y, DiIorio M, Wolfgang T, Kim EY, Dellaripa PF, Weinblatt ME, Shadick N, Doyle TJ, Sparks JA. McDermott GC, et al. Arthritis Care Res (Hoboken). 2024 Sep 11. doi: 10.1002/acr.25432. Online ahead of print. Arthritis Care Res (Hoboken). 2024. PMID: 39257341
Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis.
Zhang Q, McDermott GC, Juge PA, Chang SH, Vanni KM, Qian G, Bade KJ, Mueller KT, Kowalski EN, Saavedra AA, Sparks JA. Zhang Q, et al. Among authors: bade kj. Semin Arthritis Rheum. 2024 Dec;69:152561. doi: 10.1016/j.semarthrit.2024.152561. Epub 2024 Oct 11. Semin Arthritis Rheum. 2024. PMID: 39413452 Review.
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Venkat RK, Wang X, Patel NJ, Kawano Y, Schiff A, Kowalski EN, Cook CE, Vanni KMM, Qian G, Bade KJ, Saavedra A, Srivatsan S, Williams ZK, Wallace ZS, Sparks JA. Venkat RK, et al. Among authors: bade kj. Rheumatology (Oxford). 2024 Oct 1;63(10):2828-2837. doi: 10.1093/rheumatology/kead662. Rheumatology (Oxford). 2024. PMID: 38070152 Free PMC article.
13 results